for those malignancies studied that involved more than 20 patients , the greatest incidences of increased excretion were 66 % for spermine in patients with colon carcinoma and 50 % for putrescine and spermidine in patients with bronchogenic carcinoma .
C0037874
spermine
C0037871
patients